Thomas R. Staab II, Senior Vice President and CFO at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 9,750 shares at $7.72 ($75K) on 2019-05-16, disclosed to the SEC on 2019-05-20.
Open-market sale of $75k BCRX by Senior Vice President and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.72 | 7,250 | $56K | 75.0% |
| 2 | $7.45 | 2,500 | $19K | 25.0% |
| Total | $7.65 avg | 9,750 | $75K | 100% |
| Filing → |
| BCRX | SELL | 2019-05-13 | $224K | — | Filing → |
| BCRX | SELL | 2019-05-06 | $126K | — | Filing → |
| BCRX | SELL | 2019-04-08 | $66K | — | Filing → |